Clinically relevant drug interactions involving antimicrobials in a general hospital: a cross-sectional study

Objective: To assess the prevalence of pDDI involving antimicrobials and other standardized drugs in a large general hospital in the interior of São Paulo. Methods: quantitative study, with cross-sectional design and data collection by documentary analysis of hospital prescriptions from April to Ju...

Full description

Saved in:
Bibliographic Details
Main Authors: Larissa PAVANELLO, Fátima G. FARHAT, Rafaela P. CARVALHO, Hellen T. GREGÓRIO
Format: article
Language:EN
PT
Published: Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde 2021
Subjects:
Online Access:https://doaj.org/article/63d9deb03b604de8b4e5081ba9a6063d
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective: To assess the prevalence of pDDI involving antimicrobials and other standardized drugs in a large general hospital in the interior of São Paulo. Methods: quantitative study, with cross-sectional design and data collection by documentary analysis of hospital prescriptions from April to June 2017. Results: 66 clinically relevant pDDI were found, which corresponded to approximately 7.3% of antimicrobial prescriptions, being 93.9% (62) contraindicated / severe and 6.1% (4) moderate. There was no difference in the prevalence of clinically relevant pDDIs between critical and non-critical inpatient, in addition to all contraindicated interactions (10) having occurred in the clinical and surgical units. The most prevalent pDDI were, with respective degrees of documentation, between vancomycin and amikacin (47% - reasonable), clarithromycin and simvastatin (13.6% - good), and ciprofloxacin and simvastatin (7.6% - good). Conclusion: For the proper prevention of potential drug-related problems, mechanisms to guarantee the quality of prescriptions by trained clinical pharmacists are of fundamental importance, in addition to alert systems and drug interaction information for the health team, then ensuring quality pharmacotherapy and patient safety.